329 related articles for article (PubMed ID: 32668815)
1. Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β
Baltes F; Caspers J; Henze S; Schlesinger M; Bendas G
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668815
[TBL] [Abstract][Full Text] [Related]
2. β
Baltes F; Pfeifer V; Silbermann K; Caspers J; Wantoch von Rekowski K; Schlesinger M; Bendas G
Biochim Biophys Acta Mol Cell Res; 2020 May; 1867(5):118663. PubMed ID: 31987794
[TBL] [Abstract][Full Text] [Related]
3. Insight into Cisplatin-Resistance Signaling of W1 Ovarian Cancer Cells Emerges mTOR and HSP27 as Targets for Sensitization Strategies.
Wantoch von Rekowski K; König P; Henze S; Schlesinger M; Zawierucha P; Januchowski R; Bendas G
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287446
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Integrin-Mediated Matrix Adhesion on Cisplatin Resistance of W1 Ovarian Cancer Cells.
Wantoch von Rekowski K; König P; Henze S; Schlesinger M; Zawierucha P; Januchowski R; Bendas G
Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31779287
[TBL] [Abstract][Full Text] [Related]
5. A membrane-type-1 matrix metalloproteinase (MT1-MMP)-discoidin domain receptor 1 axis regulates collagen-induced apoptosis in breast cancer cells.
Assent D; Bourgot I; Hennuy B; Geurts P; Noël A; Foidart JM; Maquoi E
PLoS One; 2015; 10(3):e0116006. PubMed ID: 25774665
[TBL] [Abstract][Full Text] [Related]
6. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
[TBL] [Abstract][Full Text] [Related]
7. Collagen I induces discoidin domain receptor (DDR) 1 expression through DDR2 and a JAK2-ERK1/2-mediated mechanism in primary human lung fibroblasts.
Ruiz PA; Jarai G
J Biol Chem; 2011 Apr; 286(15):12912-23. PubMed ID: 21335558
[TBL] [Abstract][Full Text] [Related]
8. GPER mediates decreased chemosensitivity via regulation of ABCG2 expression and localization in tamoxifen-resistant breast cancer cells.
Yu T; Cheng H; Ding Z; Wang Z; Zhou L; Zhao P; Tan S; Xu X; Huang X; Liu M; Peng M; Qiu YA
Mol Cell Endocrinol; 2020 Apr; 506():110762. PubMed ID: 32087276
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1.
Reger De Moura C; Louveau B; Jouenne F; Vilquin P; Battistella M; Bellahsen-Harrar Y; Sadoux A; Menashi S; Dumaz N; Lebbé C; Mourah S
Oncogene; 2024 May; 43(21):1620-1630. PubMed ID: 38570692
[TBL] [Abstract][Full Text] [Related]
10. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
[TBL] [Abstract][Full Text] [Related]
11. Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells.
Vella V; Malaguarnera R; Nicolosi ML; Palladino C; Spoleti C; Massimino M; Vigneri P; Purrello M; Ragusa M; Morrione A; Belfiore A
Oncotarget; 2017 Jun; 8(26):43248-43270. PubMed ID: 28591735
[TBL] [Abstract][Full Text] [Related]
12. Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia.
Berrazouane S; Boisvert M; Salti S; Mourad W; Al-Daccak R; Barabé F; Aoudjit F
Cell Death Dis; 2019 May; 10(5):357. PubMed ID: 31043590
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Matrix-Induced Chemoresistance of Breast Cancer Cells-Deciphering Novel Potential Targets for a Cell Sensitization.
Jakubzig B; Baltes F; Henze S; Schlesinger M; Bendas G
Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30563275
[TBL] [Abstract][Full Text] [Related]
14. A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.
Menendez JA; Vellon L; Mehmi I; Teng PK; Griggs DW; Lupu R
Oncogene; 2005 Jan; 24(5):761-79. PubMed ID: 15592521
[TBL] [Abstract][Full Text] [Related]
15. Neuropilin-1 promotes the oncogenic Tenascin-C/integrin β3 pathway and modulates chemoresistance in breast cancer cells.
Naik A; Al-Yahyaee A; Abdullah N; Sam JE; Al-Zeheimi N; Yaish MW; Adham SA
BMC Cancer; 2018 May; 18(1):533. PubMed ID: 29728077
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma.
Aguilera KY; Huang H; Du W; Hagopian MM; Wang Z; Hinz S; Hwang TH; Wang H; Fleming JB; Castrillon DH; Ren X; Ding K; Brekken RA
Mol Cancer Ther; 2017 Nov; 16(11):2473-2485. PubMed ID: 28864681
[TBL] [Abstract][Full Text] [Related]
17. Cooperative effect of gefitinib and fumitremorgin c on cell growth and chemosensitivity in estrogen receptor alpha negative fulvestrant-resistant MCF-7 cells.
Liu H; Cheng D; Weichel AK; Osipo C; Wing LK; Chen B; Louis TE; Jordan VC
Int J Oncol; 2006 Nov; 29(5):1237-46. PubMed ID: 17016657
[TBL] [Abstract][Full Text] [Related]
18. Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice.
Sun X; Gupta K; Wu B; Zhang D; Yuan B; Zhang X; Chiang HC; Zhang C; Curiel TJ; Bendeck MP; Hursting S; Hu Y; Li R
J Biol Chem; 2018 Feb; 293(8):2841-2849. PubMed ID: 29298894
[TBL] [Abstract][Full Text] [Related]
19. Differences in integrin expression and signaling within human breast cancer cells.
Taherian A; Li X; Liu Y; Haas TA
BMC Cancer; 2011 Jul; 11():293. PubMed ID: 21752268
[TBL] [Abstract][Full Text] [Related]
20. TGF-β1 promotes linear invadosome formation in hepatocellular carcinoma cells, through DDR1 up-regulation and collagen I cross-linking.
Ezzoukhry Z; Henriet E; Piquet L; Boyé K; Bioulac-Sage P; Balabaud C; Couchy G; Zucman-Rossi J; Moreau V; Saltel F
Eur J Cell Biol; 2016 Nov; 95(11):503-512. PubMed ID: 27720259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]